Self-engineered binary nanoassembly enabling closed-loop glutathione depletion-amplified tumor ferroptosis

Literature Information

Publication Date 2023-09-21
DOI 10.1039/D3BM01153D
Impact Factor 6.843
Authors

Jin Lei, Shenwu Zhang, Zehua Wu, Xinxin Sun, Binghong Zhou, Peiqi Huang, Mingzhu Fang, Lin Li, Cong Luo, Zhonggui He


View Original

Abstract

Ferroptosis has emerged as a promising target for anticancer treatment, comprising iron-dependent lipid peroxidation and excessive accumulation of reactive oxygen species. Given that glutathione (GSH) overproduced in tumor cells antagonizes the cellular oxidation system, the reduction of GSH production has been extensively explored to induce ferroptosis. However, reducing GSH production alone is insufficient to trigger an intense lipid peroxidation storm. It is highly desirable to achieve systemic GSH depletion through simultaneous production and consumption intervention. Herein, we propose a bidirectional blockage strategy for closed-loop GSH depletion-amplified tumor ferroptosis. Sorafenib (Sor) and gambogic acid (GA) were elaborately fabricated as a self-engineered carrier-free nanoassembly without any nanocarrier materials. The PEGylated dual-drug nanoassembly enables favorable co-delivery and tumor-specific release of Sor and GA. Notably, a closed-loop GSH depletion is observed as a result of a Sor-induced decrease in GSH production and GA-accelerated GSH consumption in vitro and in vivo. As expected, this uniquely engineered dual-drug nanoassembly demonstrates vigorous antitumor activity in 4T1 breast tumor-bearing mice. This study presents a novel nanotherapeutic modality for ferroptosis-driven cancer treatment.

Related Literature

Revisiting the conundrum of trehalose stabilization

Nidhi Katyal, Shashank Deep

2014-10-28 Paper

DOI: 10.1039/C4CP02914C

Growth of axial nested P–N heterojunction nanowires for high performance diodes

Nan Chen, Zheng Xue, Hui Yang, Zhou Zhang, Juan Gao, Yongjun Li, Huibiao Liu

2014-11-25 Paper

DOI: 10.1039/C4CP04397A

Ab initio quantum dynamical analysis of ultrafast nonradiative transitions via conical intersections in pyrazine

Manabu Kanno, Yuta Ito, Noriyuki Shimakura, Shiro Koseki, Hirohiko Kono

2014-11-26 Paper

DOI: 10.1039/C4CP04807E

Structure of palladium nanoparticles under oxidative conditions

Cristina Popa, Tianwei Zhu, Ionut Tranca, Payam Kaghazchi, Emiel J. M. Hensen

2014-12-08 Paper

DOI: 10.1039/C4CP01761G

The role of Schottky barrier in the resistive switching of SrTiO3: direct experimental evidence

Xue-Bing Yin, Zheng-Hua Tan, Xin Guo

2014-11-07 Communication

DOI: 10.1039/C4CP04151H

Origin of surface trap states in CdS quantum dots: relationship between size dependent photoluminescence and sulfur vacancy trap states

Aisea Veamatahau, Bo Jiang, Tom Seifert, Satoshi Makuta, Kay Latham, Masayuki Kanehara, Toshiharu Teranishi

2014-12-05 Paper

DOI: 10.1039/C4CP04761C

Electronic properties of PbX3CH3NH3 (X = Cl, Br, I) compounds for photovoltaic and photocatalytic applications

Sigismund Teunis Alexander George Melissen, Frédéric Labat, Philippe Sautet, Tangui Le Bahers

2014-11-26 Paper

DOI: 10.1039/C4CP04666H

Structure and magnetic properties of (Fe2O3)n clusters (n = 1–5)

A. Erlebach, C. Hühn, R. Jana, M. Sierka

2014-06-23 Communication

DOI: 10.1039/C4CP02099E

DFT studies of oxygen dissociation on the 116-atom platinum truncated octahedron particle

Paul C. Jennings, Roy L. Johnston

2014-07-15 Paper

DOI: 10.1039/C4CP02147A

Elucidating the effect of copper as a redox additive and dopant on the performance of a PANI based supercapacitor

Kavita Pandey, Pankaj Yadav, Indrajit Mukhopadhyay

2014-11-07 Paper

DOI: 10.1039/C4CP04321A

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide

Source Journal

Biomaterials Science

Biomaterials Science
CiteScore: 11.5
Self-citation Rate: 3.4%
Articles per Year: 492

Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. Papers do not necessarily need to report a new biomaterial but should provide novel insight into the biological applications of the biomaterial. Articles that primarily focus on demonstrating novel materials chemistry and bring a molecular picture to bear on a given material’s suitability as a biomaterial are more suited to our companion journal, Journal of Materials Chemistry B. Biomaterials Science publishes primary research and review-type articles in the following areas: molecular design of biomaterials, including translation of emerging chemistries to biomaterials science of cells and materials at the nanoscale and microscale materials as model systems for stem cell and human biology materials for tissue engineering and regenerative medicine (Nano)materials and (nano)systems for therapeutic delivery interactions at the biointerface biologically inspired and biomimetic materials, including bio-inspired self-assembly systems and cell-inspired synthetic tools next-generation biomaterials tools and methods

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.